Fosun Pharma Plans To Privatize Tongjitang, Establish Joint Venture
This article was originally published in PharmAsia News
Executive Summary
Fosun Industrial and Hanmax Investment, both subsidiaries of Fosun Pharma, recently announced plans to establish a new joint venture company as part of a proposal to privatize Tongjitang Chinese Medicines